A Tefferi, M Q Lacy, P J Kurtin. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Cyclophosphamide/adverse effectsCyclophosphamide/therapeutic useCyclosporine/adverse effectsCyclosporine/therapeutic useGene Rearrangement, T-LymphocyteHumansImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/pharmacologyLeukemia-Lymphoma, Adult T-Cell/etiologyLeukemia-Lymphoma, Adult T-Cell/geneticsPreleukemia/drug therapyPreleukemia/geneticsPreleukemia/pathologyPrognosisRed-Cell Aplasia, Pure/drug therapyRed-Cell Aplasia, Pure/geneticsRed-Cell Aplasia, Pure/pathology
Substances： See more » Immunosuppressive AgentsCyclosporineCyclophosphamide
Year: 1996 PMID： 8874229
Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113